Epilepsy Drugs Market is likely to reach nearly USD 5.5 Billion by the year end of 2021.
Market growth can be attributed to factors such as rising incidence of neurological disorders, growing disease awareness, introduction of novel antiepileptic drugs (AEDs), strong government support and initiatives. Moreover, increasing R&D investment and launch of extended-release formulations are further expected to fuel the market growth. However, high cost of patented drugs, concerns over decreasing healthcare costs as part of government austerity measures, particularly in Europe and low accessibility to antiepileptic drugs in low and middle income countries, are likely to restrict the market growth.
Vimpat is the undisputed leading drug of Global Epilepsy Drugs Market. It has a market share of nearly 22% in 2016 and is expected that Vimpat will gain its momentum till the forecasting period. Keppra was the second highest market share taker with more than 19% share in 2016 but the prospect of this drug will change due to the patent expiration in 2018 and its share decline to XX% by 2021. It is expected that Lamictal will be second leading drug with nearly XX% share by 2021. Onfi hold the third highest share of the Epilepsy Drugs market, being followed by Depakine by the year end of 2021.
The research report titled Epilepsy Drugs Market: Global Demand, Growth Potential & Opportunity Outlook 2021 examines the market, competitive landscape and trends of the Global Epilepsy Drug Market. This report analyzes market data and provides a better understanding of Epilepsy Drugs sales value and demand in the Global Market. Market outlook in value terms for the forecasted period for Epilepsy Drugs Market has been detailed in the report. Key trends in terms of collaborations, partnerships and licensing agreements are analysed with details. The report also explores detailed description of growth drivers and inhibitors of the Global Epilpesy Drugs Market.
Avail Complete research data at: https://www.marketinsightsreports.com/report/purchase/0718929?mode=su
The report concludes with the profiles of major players in the Epilepsy Drugs Market such as UCB, EISAI, Pfizer, Sanofi and Lundbeck. The major market players are evaluated on various parameters such as company overview and latest development and trends in the Epilepsy Drugs Market
Key Topics Covered in the Report
- Worldwide Epilepsy Drugs Market Analysis (2013 – 2021)
- Worldwide Epilepsy Drugs Market Share (2013 – 2021)
- Worldwide Epilepsy Drugs Brand Market Performance (2013 – 2021)
- Epilepsy Drugs Market – Major Deal Types
- Key Companies Analysis
- Key Drivers and Inhibitors of the Epilepsy Drugs Market
Key Epilepsy Drugs Covered in the Report are as follows:
- Neurontin (Gabapentin)
- Depakine (Sodium Valproate)
- Sabril (Vigabatrin)
- Zonegran (Zonisamide)
- Zebinix (Eslicarbazepine Acetate)
Key Companies Covered in the Report are as follows:
DPI Research’s team of researchers and analysts use a variety of research sources for making a report. Most of the data – information and statistics – for our products is gathered using the secondary research by our in–house team of researchers. The main objective of DPI Research’s secondary research exercise is to exhaust all sources of published information including websites of government agencies, consumer and trade associations, annual reports and accounts of companies, news articles from well–known publications and online databases. The data thus gathered is send to our team of analysts who verify that data and look for research gaps. These gaps are filled through primary research, that is, our analysts gain information from various agencies, associations and companies using customer surveys, telephonic and email interviews, etc. Finally, all the information collected using secondary and primary research is analyzed and synthesized by our analysts and is presented in a report.
Industry information and data for this report has been sourced through numerous channels including publically available information from companies’ and industry association websites. For industry sizing, segmentation and trends, apart from desk research, we have contacted industry experts and executives from various companies.
Market forecasts are done using statistical forecasting techniques based on historic performance. Statistical tools are further supplemented with qualitative parameters like industry expectation, economic drivers, new product development, customer surveys, ongoing research, etc.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Reasons for Buying this Report
- This report provides pin-point analysis for changing competitive dynamics
- It provides a forward looking perspective on different factors driving or restraining market growth
- It provides a growth map over time to understand the industry growth rate
- It provides a Five to seven-year forecast assessed on the basis of how the market is predicted to grow
- It helps in understanding the key product segments and their future
- It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
- It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
- It provides distinctive graphics and exemplified SWOT analysis of major market segments.
About Us: –
MarketInsightsReports provides syndicated market research reports to industries, organizations or even individuals with an aim of helping them in their decision making process. These reports include in-depth market research studies i.e. market share analysis, industry analysis, information on products, countries, market size, trends, business research details and much more. MarketInsightsReports provides global and regional market intelligence coverage, a 360-degree market view which includes statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.
+1 (704) 266-3234 |email@example.com
Connect with us On: